Publications by authors named "H Naganawa"
Article Synopsis
- NMV/RTV and ESV are oral antivirals for COVID-19 that can interact with the drug tacrolimus (TAC), used by kidney transplant patients, leading to increased TAC levels.
- In three case studies with kidney transplant recipients, TAC levels rose significantly when patients took NMV/RTV (over tenfold) and moderately with ESV (about threefold).
- The findings recommend discontinuing TAC while on NMV/RTV and suggest that a reduced TAC dose may be adequate when using ESV.
Background: Percutaneous coronary intervention using a drug-eluting stent (DES) is a common therapeutic option for acute coronary syndrome (ACS). However, stent-associated complications, such as bleeding associated with dual antiplatelet therapy, in-stent restenosis, stent thrombosis, and neoatherosclerosis, remain. Drug-coated balloons (DCBs) are expected to reduce stent-associated complications.
View Article and Find Full Text PDFRecently, trans-radial intervention has gained popularity as a common procedure to reduce hemorrhagic complications. However, the cuff-type hemostatic device (TR Band) previously used at our institution required 6 h to achieve hemostasis. Since July 2016, we have been using the VasoSTAT, a new hemostatic device that could achieve hemostasis in 4 h.
View Article and Find Full Text PDF